The wound healing response of the vascular wall to injury involves re-endothelialisation of the denuded luminal surface and thickening of the intimal area (intimal hyperplasia), as expressed by the intimal-tomedial area ratio (I/M). Candesartan, at doses of 1 mg/kg/day or higher, has been reported to attenuate the intimal hyperplastic response. We tested the hypothesis that candesartan, at doses lower than those associated with attenuation of intimal hyperplasia, may affect re-endothelialisation. New Zealand White rabbits were subjected to balloon catheter injury to the thoracic aorta. Candesartan, at doses of 50, 100, and 500 µg/kg/day, was delivered via an Alzet pump placed in the abdomen one week prior to aortic injury. There was no attenuation of the hyperplastic response of the aortic wall. However, at 50 µg/kg/day the rate of reendothelialisation was significantly increased. These data suggest that candesartan may exhibit pleiotropic effects on vascular wound healing, in addition to the wellknown effect of attenuating the development of intimal hyperplasia.
Introduction
The physiological response to arterial injury has been well established in various animal models and can be categorised into three primary phases: elastic recoil, endothelial damage/denudation with subsequent mural thrombus formation and neointimal expansion. 1 In many instances, the physiological events following arterial injury ultimately culminate in the development of intimal hyperplasia (vascular smooth muscle cell proliferation and matrix deposition), which potentially contributes to the problem of restenosis in humans. 2 In some instances, a stent is placed at the site of angioplasty. This emplacement prevents the loss of luminal diameter due to elastic recoil. Intimal hyperplasia is thought to play a major role in the restenosis that occurs following stent emplacement. It has been proposed that attenuation of neointimal thickening may be a function of the restoration of the endothelial cell layer and, thus, the rate of endothelial cell regrowth. [3] [4] [5] [6] However, it has also been suggested that attenuation of intimal thickening precedes reendothelialisation and provides a luminal surface more conducive to endothelial regrowth.
Under normal conditions, the endothelium plays an important role in regulating smooth muscle cell proliferation, by acting as a barrier between underlying smooth muscle cells and mitogens in the circulation and by regulating the growth-promoting effects of angiotensin II (Ang II). [3] [4] [5] [6] Endothelial denudation exposes the smooth muscle cells to mitogens, reveals pro-aggregatory structures, and activates platelets, which release procoagulant, vasoconstrictive and mitogenic substances. 7 The myointimal hyperplasia arising from endothelial denudation has been reported to be significantly attenuated by the administration either angiotensin-converting enzyme inhibitors (ACE-I) or Ang II type 1 (AT 1 )-receptor blockers e.g., candesartan. [8] [9] [10] To investigate potential pleiotropic responses to candesartan, doses which are not associated with inhibition of intimal hyperplasia (50, 100, and 500 µg/kg/day), were employed. This study was undertaken to determine whether candesartan affects re-endothelialisation at doses that do not attenuate intimal hyperplasia.
Materials and methods
Male New Zealand White rabbits, weighing 3.0-3.5 kg, were used for all experiments. All procedures were carried out under protocols approved by the Tulane University Animal Care and Research Committee.
Alzet pumps were inserted into the abdomen to deliver candesartan at concentrations of 50, 100, or 500 µg/kg/day one week prior to aortic injury. Vascular injury was produced using a 4-Fr embolectomy catheter. Rabbits were anaesthetised using a mixture of ketamine and xylazine (50 mg/kg i.m. ketamine, 10 mg/kg i.m. xylazine). Nitrous oxide was used as an inhalational anaesthetic, and pentobarbital sodium was given (25 mg/kg i.v.). The superficial femoral artery was isolated through a short incision in the right groin. The catheter was inserted through an arteriotomy and was passed to the level estimated to be the ascending aorta. The balloon was inflated with saline and withdrawn to the level of the abdominal aorta. This was repeated three times. Because the response to injury is directly proportional to the degree of injury induced, the catheter was attached to a force gauge to consistently and reproducibly maintain a constant pressure transmitted to the vessel wall (~300 g). Sham-operated animals underwent simple ligation of the femoral artery. These procedures were conducted under sterile conditions in a vivarial operating room. After the operation, the rabbits were housed in the vivarium and given water and standard rabbit diet ad libitum until the time of death. Animals were given a lethal dose of pentobarbital sodium (250 mg/kg i.v.), and the thoracic aortae were removed. Upon removal,aortae were placed in ice-cold Krebs buffer (in mM: 118 NaCl, 4.7 KCl, 5.6 glucose, 25 NaHCO3, 1.5 CaCl2, 1.2 KH2PO4, and 1.2 MgSO4, pH 7.4) at which time fat and loose adventitia were dissected away, and vessels were cut into 3 mm rings for fixation.
To analyse endothelial regrowth, animals received an injection of 0.5% Evans blue dye solution (3 ml/kg i.v.) 1 hour before death. 7 This dye binds to proteins within the circulation, which subsequently bind to denuded areas of aorta, staining them blue. Areas of endothelial regrowth remain unstained. Harvested aortic segments, three collateral vessels in length, were cut longitudinally along the ventral surface and were mounted on glass microscope slides. Aortic segments were then digitised using an HP ScanJet 4c, and endothelial regrowth was measured using IP Lab Spectrum software and reported as percentage regrowth.
For the intimal/medial (I/M) ratios, 3 mm rings were also cut from the aorta and embedded in paraffin. The paraffin-embedded rings were then cut into 6 µ slices on a microtome and placed on slides. The slides were stained, using Verhof's Van Geison elastic stain, and analysed using IP Lab spectrum. All the above methods are as previously published. 7 There was no statistically significant change in the medial area following catheter injury, as previously published. 6, 7, 11 Thus, changes in the I/M ratio reflect changes in the intima.
The data obtained within an experimental group were averaged and reported as mean±SEM. These data were then analysed using the Statview SE+ statistics package, using ANOVA and the Scheffé's F-test to determine differences between the groups. p<0.05 was considered significant. Figure 1A is a micrograph of the luminal surface of the thoracic aorta from a control animal following Evans Blue staining. Note the absence of staining by the dye, indicating an intact endothelial layer. Figure 1B is a micrograph of the luminal surface of the thoracic aorta from an animal two weeks following injury. Evans Blue dye is used to highlight regions that remain denuded, whereas white areas indicate regions of re-endothelialisation. Figure  1C is a micrograph of the luminal surface of the thoracic aorta from a candesartan-treated animal two weeks following injury after staining with Evans Blue dye. Note the increased areas of reendothelialisation as compared with Figure 1B . Figure 2 shows the rate of re-endothelialisation and demonstrates that the group of animals treated with 50 µg/kg/day of candesartan displayed a significantly increased percentage re-endothelialisation, when compared with the other groups. Figure 3 displays the calculated I/M ratios for the three groups of animals with no significant decrease in I/M ratios for candesartan-treated animals. 
Results

Figure 2
Rate of re-endothelialisation at two weeks following catheter injury. Candesartan-treated animals received 50 or 100 µg/kg/day as described in the methods section. 
Conclusions
As predicted, attenuation of neointimal thickening was not observed at the doses of candesartan employed. However, as shown in Figures 2 and 3 , there is a significant increase in the rate of reendothelialisation in the 50 µg/kg/day group, as compared with the control rabbits, whereas the intimal thickening in the 50 µg/kg/day group was not significantly decreased from the controls, as illustrated in Figure 3 . This suggests a potential effect of candesartan which is unrelated to attenuation of intimal thickening. It is possible that there was an attenuation in intimal thickening in the areas beneath the sites of re-endothelialisation, as we have previously published. 7 No histological determination was made in the present study.
Candesartan, at a dose of 3 mg/kg/day, has been reported to decrease the hyperplastic response to balloon catheter injury to the canine coronary artery. 9, 10 It is interesting to note that, whereas there was an increased rate of reendothelialisation at 50 µg/kg/day of candesartan, there was no effect on hyperplasia. This is the first report, to our knowledge, of a disassociation between these two pathophysiological processes. The physiological/pathophysiological implications of the observations in this study are currently uncertain.
It is interesting to speculate on the possible mechanisms associated with these events: First, increased activation of the AT 2 -receptor in the face of AT 1 -receptor blockade may have augmented endothelial regrowth. Secondly, the neoendothelium formed may have been functionally abnormal and, therefore, did not affect the hyperplastic response. It is possible that the association between increased re-endothelialisation and attenuation of intimal hyperplasia is coincidental and not mechanistically related, though other speculations are also possible. 
